Morgan Stanley
XTNT icon

Morgan Stanley’s Xtant Medical Holdings XTNT Stock Holding History

Morgan Stanley’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$628 Hold
1,125
– – ﹤0.01% 7586
2025
Q4 		$882 Buy
+1,125
New +$818 ﹤0.01% 7395
2024
Q2 		– Sell
-1,275
Closed -$1.49K – 7969
2024
Q1 		$1.49K Buy
+1,275
New +$1.4K ﹤0.01% 7115
2023
Q4 		– Sell
-29
Closed -$32 – 7914
2023
Q3 		$32 Sell
29
-282
-91% -$303 ﹤0.01% 7509
2023
Q2 		$289 Hold
311
– – ﹤0.01% 7423
2023
Q1 		$198 Hold
311
– – ﹤0.01% 7517
2022
Q4 		$205 Buy
311
+281
+937% +$184 ﹤0.01% 7644
2022
Q3 		$0 Buy
30
+1
+3% +$1 ﹤0.01% 7899
2022
Q2 		$0 Sell
29
-9
-24% -$5 ﹤0.01% 7998
2022
Q1 		$0 Buy
38
+8
+27% +$5 ﹤0.01% 8142
2021
Q4 		$0 Buy
30
+1
+3% +$1 ﹤0.01% 8129
2021
Q3 		$0 Hold
29
– – ﹤0.01% 8036
2021
Q2 		$0 Hold
29
– – ﹤0.01% 7812
2021
Q1 		$0 Hold
29
– – ﹤0.01% 7577
2020
Q4 		$0 Sell
29
-9,672
-100% -$12.5K ﹤0.01% 7127
2020
Q3 		$8K Hold
9,701
– – ﹤0.01% 6339
2020
Q2 		$9K Hold
9,701
– – ﹤0.01% 6193
2020
Q1 		$6K Hold
9,701
– – ﹤0.01% 6161
2019
Q4 		$16K Sell
9,701
-164
-2% -$336 ﹤0.01% 6158
2019
Q3 		$28K Sell
9,865
-298
-3% -$828 ﹤0.01% 5916
2019
Q2 		$30K Sell
10,163
-661
-6% -$2.03K ﹤0.01% 5808
2019
Q1 		$33K Hold
10,824
– – ﹤0.01% 5840
2018
Q4 		$17K Hold
10,824
– – ﹤0.01% 6052
2018
Q3 		$42K Hold
10,824
– – ﹤0.01% 5922
2018
Q2 		$60K Sell
10,824
-446
-4% -$2.98K ﹤0.01% 5876
2018
Q1 		$89K Buy
11,270
+10,699
+1,874% +$70.4K ﹤0.01% 5738
2017
Q4 		$4K Sell
571
-179
-24% -$1.41K ﹤0.01% 6367
2017
Q3 		$6K Buy
750
+208
+38% +$1.86K ﹤0.01% 6263
2017
Q2 		$4K Hold
542
– – ﹤0.01% 6390
2017
Q1 		$4K Sell
542
-83
-13% -$510 ﹤0.01% 6393
2016
Q4 		$4K Sell
625
-83
-12% -$716 ﹤0.01% 6310
2016
Q3 		$10K Sell
708
-21
-3% -$386 ﹤0.01% 6116
2016
Q2 		$16K Buy
729
+57
+8% +$1.47K ﹤0.01% 5927
2016
Q1 		$22K Buy
672
+450
+203% +$14.4K ﹤0.01% 5892
2015
Q4 		$8K Buy
+222
New +$7.8K ﹤0.01% 6290
2015
Q2 		– Sell
-472
Closed -$23K – 6761
2015
Q1 		$23K Buy
472
+250
+113% +$10.1K ﹤0.01% 6013
2014
Q4 		$8K Buy
222
+9
+4% +$374 ﹤0.01% 6257
2014
Q3 		$11K Buy
213
+41
+24% +$2.73K ﹤0.01% 6170
2014
Q2 		$14K Buy
172
+74
+76% +$6.28K ﹤0.01% 6110
2014
Q1 		$10K Hold
98
– – ﹤0.01% 6130
2013
Q4 		$6K Sell
98
-8
-8% -$511 ﹤0.01% 6128
2013
Q3 		$9K Hold
106
– – ﹤0.01% 5313
2013
Q2 		$6K Buy
+106
New +$8.76K ﹤0.01% 5312

Other funds holding XTNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Morgan Stanley's XTNT Position: Q1 2026 in Review

Morgan Stanley held its Xtant Medical Holdings (XTNT) position steady in Q1 2026 at 1,125 shares worth $628. The position accounts for ﹤0.01% of the portfolio, ranked #7586.

Morgan Stanley first reported a position in XTNT in Q2 2013 and has held it in 43 quarters since. The position peaked at $89K in Q1 2018. 34 funds tracked by Wall St. Rank hold XTNT as of Q1 2026.

  • Morgan Stanley held 1,125 shares of Xtant Medical Holdings worth $628 as of Q1 2026.
  • Morgan Stanley left its Xtant Medical Holdings share count unchanged in Q1 2026.
  • Xtant Medical Holdings made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7586 holding.
  • Morgan Stanley first reported a position in Xtant Medical Holdings in Q2 2013 and has held it in 43 quarters since.
  • Morgan Stanley's Xtant Medical Holdings position peaked at $89K in Q1 2018.
  • 34 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.